Healthcare Times Utah: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare Times Utah.

Press releases published on October 2, 2026

2 hours ago

Hyperion DeFi Commences Share Buybacks, Retires All Legacy Debt, and Commits to Further Capital Optimization

Indeterminate GlobeNewswire

2 hours ago

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

2 hours ago

Celcuity Appoints David Gryska To Its Board Of Directors

Indeterminate GlobeNewswire

2 hours ago

Persephone Biosciences to Provide 50,000 Free Doses of Groundbreaking Infant and Toddler Synbiotics

Indeterminate GlobeNewswire

2 hours ago

Integra LifeSciences Announces Launch of $600 Million Senior Secured Term Loan B

Indeterminate GlobeNewswire

2 hours ago

Surrozen Announces FDA Clearance of IND Application for SZN-8141 for the Treatment of Diabetic Macular Edema

Indeterminate GlobeNewswire

2 hours ago

Damora Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

3 hours ago

Cytokinetics Announces Four Upcoming Presentations at the HFSA Annual Scientific Meeting 2026

Indeterminate GlobeNewswire

3 hours ago

Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

3 hours ago

Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

3 hours ago

InflaRx to Present Late-Breaking Pre-clinical Data on Izicopan at Kidney Week 2026

Indeterminate GlobeNewswire

3 hours ago

Published Human Research Gives Family Caregivers a Way to Evaluate Joint Supplements

Indeterminate GlobeNewswire

3 hours ago

Walden Biosciences to Present Phase 1+ and Phase 2 Data for WAL0921 at American Society of Nephrology Kidney Week

Indeterminate GlobeNewswire

3 hours ago

Cartesian Therapeutics Announces New Employment Inducement Grants

Indeterminate GlobeNewswire

3 hours ago

Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

3 hours ago

Pyxis Oncology Announces Closing of Up to $282.6 Million Public Offering

Indeterminate GlobeNewswire

4 hours ago

Digbi Health Unifies Metabolic, Inflammatory and Hormonal Care on One Precision Biology Telehealth Platform

Indeterminate GlobeNewswire

4 hours ago

The Ensign Group Adds New Operations in Colorado

Indeterminate GlobeNewswire

4 hours ago

The Ensign Group Announces Expansion Into Florida

Indeterminate GlobeNewswire

4 hours ago

The Ensign Group Adds Operations in Washington

Indeterminate GlobeNewswire